Altimmune, Inc. (ALT)

3.585 -0.02 (-0.69%) USD  |  NASDAQ  |  Dec 31, 11:16
More

Altimmune Operating Income (Quarterly YoY Growth)

Operating Income (Quarterly YoY Growth) Chart

View Operating Income (Quarterly YoY Growth) for ALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Quarterly YoY Growth) Range, Past 5 Years

View Operating Income (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Quarterly YoY Growth) Benchmarks

View Operating Income (Quarterly YoY Growth) Benchmarks
Start Trial
Viking Therapeutics, Inc. Upgrade
Amgen, Inc. Upgrade
Rhythm Pharmaceuticals, Inc. Upgrade
Terns Pharmaceuticals, Inc. Upgrade
X4 Pharmaceuticals, Inc. Upgrade